Literature DB >> 648025

Immune complexes in acute and chronic liver disease.

H C Thomas, D De Villiers, B Potter, H Hodgson, S Jain, D P Jewell, S Sherlock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 648025      PMCID： PMC1541227     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  22 in total

1.  Isolation and characterization of C1q, a subcomponent of the first component of complement, from human and rabbit sera.

Authors:  K B Reid; D M Lowe; R R Porter
Journal:  Biochem J       Date:  1972-12       Impact factor: 3.857

2.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

3.  Role of the liver in controlling the immunogenicity of commensal bacteria in the gut.

Authors:  H C Thomas; R N McSween; R G White
Journal:  Lancet       Date:  1973-06-09       Impact factor: 79.321

4.  Role of immune complexes involving SH antigen in pathogenesis of chronic active hepatitis and polyarteritis nodosa.

Authors:  A M Prince; C Trepo
Journal:  Lancet       Date:  1971-06-26       Impact factor: 79.321

5.  Serum immunoglobulins, complement component levels and autoantibodies in liver disease.

Authors:  R A Thompson; R Carter; R P Stokes; A M Geddes; J A Goodall
Journal:  Clin Exp Immunol       Date:  1973-07       Impact factor: 4.330

6.  Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease.

Authors:  N Eleftheriou; H C Thomas; J Heathcote; S Sherlock
Journal:  Lancet       Date:  1975-12-13       Impact factor: 79.321

7.  Complement levels in acute infectious hepatitis and serum hepatitis.

Authors:  J C Kosmidis; L K Leader-Williams
Journal:  Clin Exp Immunol       Date:  1972-05       Impact factor: 4.330

8.  The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis. Complement activation and characterization of circulating immune complexes.

Authors:  J R Wands; E Mann; E Alpert; K J Isselbacher
Journal:  J Clin Invest       Date:  1975-05       Impact factor: 14.808

9.  Inactivator of the third component of complement as an inhibitor in the properdin pathway.

Authors:  C A Alper; F S Rosen; P J Lachmann
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

10.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321
View more
  47 in total

Review 1.  Recent developments in primary biliary cirrhosis: etiology and treatment.

Authors:  U Hopf; R Stemerowicz
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

2.  Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis.

Authors:  H Muro; H Shirasawa; I Kosugi; S Nakamura
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

3.  Studies on circulating soluble immune complexes of the liver disease. 1. Inhibition assay of polyclonal rheumatoid factor binding to IgG-sepharose.

Authors:  J Narumoto; T Arima; K Kunishi; T Yasuhara; K Suwaki; H Shimomura; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1979-12

4.  Serum complement components in patients with trachoma.

Authors:  D K Sen; G S Sarin; M Hiranandani; U K Baveja
Journal:  Br J Ophthalmol       Date:  1985-09       Impact factor: 4.638

5.  Polyclonal B cell activation, circulating immune complexes and autoimmunity in human american visceral leishmaniasis.

Authors:  B Galvão-Castro; J A Sá Ferreira; K F Marzochi; M C Marzochi; S G Coutinho; P H Lambert
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

6.  [Circulating immune complexes before and after kidney allotransplantation].

Authors:  G Keusch; H M Vonwiller; A von Felten; F Bammatter; H R Burger; F Largiadèr; U Binswanger
Journal:  Klin Wochenschr       Date:  1984-04-16

7.  Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.

Authors:  J Narumoto
Journal:  Gastroenterol Jpn       Date:  1981

8.  Significance of circulating HBs antigen-antibody immune complexes in patients with HBs antigen-positive liver disease.

Authors:  K Sugiura; Y Hasumura; J Takeuchi
Journal:  Gastroenterol Jpn       Date:  1982

9.  Platelet-associated IgG in hepatitis and cirrhosis.

Authors:  D Graber; D Giuliani; C M Leevy; B S Morse
Journal:  J Clin Immunol       Date:  1984-03       Impact factor: 8.317

10.  Complement activation in chronic liver disease.

Authors:  L E Munoz; D De Villiers; D Markham; K Whaley; H C Thomas
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.